Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-15
2005-02-15
Weddington, Kevin E. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06855728
ABSTRACT:
The invention is directed to small organic molecules having the ability to mimic or agonize hepatocyte growth factor/scatter factor (HGF/SF) activity, or inhibit or antagonize HGF/SF activity, the former useful for promoting, for example, vascularization of tissues or organs for promoting wound or tissue healing, or augmenting or restoring blood flow to ischemic tissues such as the heart following myocardial infarction. Inhibition of cellular growth or proliferation is beneficial in the treatment, for example, of inflammatory diseases such as inflammatory joint and skin diseases, and dysproliferative diseases such as cancer.
REFERENCES:
patent: 6162819 (2000-12-01), Schindler et al.
patent: 6589997 (2003-07-01), Pillarisetti et al.
patent: 6610726 (2003-08-01), Pillarisetti et al.
Goldberg Itzhak D.
Pillarisetti Sivaram
Klauber & Jackson
North Shore-Long Island Jewish Health System
Weddington Kevin E.
LandOfFree
Small-molecule modulators of hepatocyte growth factor /... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small-molecule modulators of hepatocyte growth factor /..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small-molecule modulators of hepatocyte growth factor /... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3480525